JP2023536938A5 - - Google Patents
Info
- Publication number
- JP2023536938A5 JP2023536938A5 JP2023507688A JP2023507688A JP2023536938A5 JP 2023536938 A5 JP2023536938 A5 JP 2023536938A5 JP 2023507688 A JP2023507688 A JP 2023507688A JP 2023507688 A JP2023507688 A JP 2023507688A JP 2023536938 A5 JP2023536938 A5 JP 2023536938A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- crystalline form
- quinazolin
- benzonitrile
- oxo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025147197A JP2026004313A (ja) | 2020-08-06 | 2025-09-04 | ４－（７－ヒドロキシ－２－イソプロピル－４－オキソ－４ｈ－キナゾリン－３－イル）－ベンゾニトリルの結晶形態及びその製剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2020107444 | 2020-08-06 | ||
| CNPCT/CN2020/107444 | 2020-08-06 | ||
| PCT/IB2021/057165 WO2022029656A1 (en) | 2020-08-06 | 2021-08-04 | Crystalline forms of 4-(7-hydroxy-2-isopropyl-4-oxo-4h-quinazolin-3-yl)-benzonitrile and formulations thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025147197A Division JP2026004313A (ja) | 2020-08-06 | 2025-09-04 | ４－（７－ヒドロキシ－２－イソプロピル－４－オキソ－４ｈ－キナゾリン－３－イル）－ベンゾニトリルの結晶形態及びその製剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023536938A JP2023536938A (ja) | 2023-08-30 |
| JP2023536938A5 true JP2023536938A5 (enExample) | 2024-08-13 |
Family
ID=77358315
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023507688A Pending JP2023536938A (ja) | 2020-08-06 | 2021-08-04 | ４－（７－ヒドロキシ－２－イソプロピル－４－オキソ－４ｈ－キナゾリン－３－イル）－ベンゾニトリルの結晶形態及びその製剤 |
| JP2025147197A Pending JP2026004313A (ja) | 2020-08-06 | 2025-09-04 | ４－（７－ヒドロキシ－２－イソプロピル－４－オキソ－４ｈ－キナゾリン－３－イル）－ベンゾニトリルの結晶形態及びその製剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025147197A Pending JP2026004313A (ja) | 2020-08-06 | 2025-09-04 | ４－（７－ヒドロキシ－２－イソプロピル－４－オキソ－４ｈ－キナゾリン－３－イル）－ベンゾニトリルの結晶形態及びその製剤 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US12459902B2 (enExample) |
| EP (1) | EP4192466A1 (enExample) |
| JP (2) | JP2023536938A (enExample) |
| CN (1) | CN116419918A (enExample) |
| WO (1) | WO2022029656A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4431497A1 (en) * | 2019-02-15 | 2024-09-18 | Bausch + Lomb Ireland Limited | Crystalline forms of 4-(7-hydroxy-2-isopropyl-4-oxo-4h-quinazolin-3-yl)-benzonitrile and formulations thereof |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3931319A (en) | 1974-10-29 | 1976-01-06 | Millmaster Onyx Corporation | Capped polymers |
| US4027020A (en) | 1974-10-29 | 1977-05-31 | Millmaster Onyx Corporation | Randomly terminated capped polymers |
| US4525346A (en) | 1981-09-28 | 1985-06-25 | Alcon Laboratories, Inc. | Aqueous antimicrobial ophthalmic solutions |
| US4407791A (en) | 1981-09-28 | 1983-10-04 | Alcon Laboratories, Inc. | Ophthalmic solutions |
| US4836986A (en) | 1984-09-28 | 1989-06-06 | Bausch & Lomb Incorporated | Disinfecting and preserving systems and methods of use |
| US5037647A (en) | 1988-09-15 | 1991-08-06 | Alcon Laboratories, Inc. | Aqueous antimicrobial opthalmic solutions comprised of quaternary ammonium compound, citric acid, citrate and sodium chloride |
| US5145643A (en) | 1990-01-05 | 1992-09-08 | Allergan, Inc. | Nonoxidative ophthalmic compositions and methods for preserving and using same |
| US5300287A (en) | 1992-11-04 | 1994-04-05 | Alcon Laboratories, Inc. | Polymeric antimicrobials and their use in pharmaceutical compositions |
| GB0412769D0 (en) | 2004-06-08 | 2004-07-07 | Novartis Ag | Organic compounds |
| GB0525068D0 (en) * | 2005-12-08 | 2006-01-18 | Novartis Ag | Organic compounds |
| US8349852B2 (en) | 2009-01-13 | 2013-01-08 | Novartis Ag | Quinazolinone derivatives useful as vanilloid antagonists |
| US20150352176A1 (en) * | 2014-06-06 | 2015-12-10 | Newport Research, Inc. | Oil-free and fat-free aqueous suspensions of cyclosporin |
| JP6994061B2 (ja) * | 2019-02-15 | 2022-01-14 | ノバルティス アーゲー | ４－（７－ヒドロキシ－２－イソプロピル－４－オキソ－４ｈ－キナゾリン－３－イル）－ベンゾニトリルの製剤 |
| KR20210129677A (ko) * | 2019-02-15 | 2021-10-28 | 노파르티스 아게 | 안구 표면 통증의 치료 방법 |
| EP4431497A1 (en) * | 2019-02-15 | 2024-09-18 | Bausch + Lomb Ireland Limited | Crystalline forms of 4-(7-hydroxy-2-isopropyl-4-oxo-4h-quinazolin-3-yl)-benzonitrile and formulations thereof |
-
2021
- 2021-08-04 WO PCT/IB2021/057165 patent/WO2022029656A1/en not_active Ceased
- 2021-08-04 US US18/040,552 patent/US12459902B2/en active Active
- 2021-08-04 JP JP2023507688A patent/JP2023536938A/ja active Pending
- 2021-08-04 CN CN202180066886.8A patent/CN116419918A/zh active Pending
- 2021-08-04 EP EP21755574.7A patent/EP4192466A1/en active Pending
-
2025
- 2025-09-04 JP JP2025147197A patent/JP2026004313A/ja active Pending